Mediwelcome Healthcare Management & Technology Inc.

Mediwelcome Healthcare Management & Technology Inc.

HHKEX:2159
1.56
HKD
-0.13
(-7.69%)
439.74MMarket Cap
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.29
1.49
2.14
2.16
3.91
1.74
1.73
1.68
2.05
- -
Basic EPS, GAAP
0.15
0.19
0.1
0.11
0.03
-0.48
-0.49
-0.24
0.04
- -
Free Cash Flow per Basic Share
-0.03
0.27
-0.04
0.09
-0.14
-0.12
-0.4
-0.14
0.02
- -
Dividend per Share
- -
0.07
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.47
0.59
0.68
0.81
1.42
0.98
0.61
0.37
0.41
0.48
Tangible Book Value per Share
0.46
0.58
0.56
0.67
1.21
0.82
0.61
0.37
0.38
-0.37
Basic Weighted Avg Shares
200
200
200
200
181
186
191
191
228
246
Sales/Revenue/Turnover
259
299
427
432
708
323
331
322
468
- -
Operating Margin (%)
15.26
16.6
7.34
5.32
-0.28
-28.14
-22.01
-10.56
0.51
- -
Depreciation Expense
8
8
11
18
19
21
21
10
5
- -
Net Income, GAAP
30
38
21
21
5
-89
-94
-45
10
- -
Effective Tax Rate (%)
20.73
19.28
15.07
1.36
6.91
- -
- -
- -
- -
- -
Profit Margin (%)
11.46
12.72
4.88
4.87
0.66
-27.58
-28.4
-14.07
2.13
- -
Working Capital
88
69
96
117
218
143
89
44
74
-47
LT Debt
1
3
- -
23
16
8
2
4
3
- -
Total Equity
99
127
145
171
293
201
120
73
105
180
Return on Invested Capital (%)
- -
31.07
14.52
12.76
2.04
- -
- -
- -
7.83
- -
Return on Capital (%)
- -
31.01
14.04
12.15
2.04
- -
- -
- -
10.28
- -
Return on Common Equity (%)
- -
35.75
16.37
14.17
2.09
-37.31
-60.48
-48.32
10.95
- -

Capital Structure

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
46
52
65
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
191
271
271
Market Capitalization
154
286
380

Working Capital

CNY

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
191
156
200
Cash, Cash Equivalents & STI
94
99
139
Accounts Receivable, Net
26
29
22
Inventories
- -
- -
- -
Total Current Liabilities
147
83
248
Payables & Accruals
- -
- -
- -
ST Debt
46
52
65
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
0.94%
43.81%
Free Cash Flow
- -
-37.84%
-112.71%
Net Income, GAAP
- -
-453.37%
-122.08%
Sales/Revenue/Turnover
- -
10.91%
45.55%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
322
2025
- -
- -
468
2026
- -
- -
- -

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.24
2025
- -
- -
0.04
2026
- -
- -
- -

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Liang Wang
Full Time Employees
165
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Block B, Greenland Center Beijing BE China
IPO Date
Jan 19, 2021
Business
Mediwelcome Healthcare Management & Technology Inc. (2159.HK), an investment holding company incorporated in the Cayman Islands, provides integrated healthcare marketing solutions primarily in the People's Republic of China. The company offers an academic conference management system for digital medical conference management; scientific data reporting system for single-disease clinical research data collection; health education media including a health science cloud platform, patient care center, patient management center, and health education media; medical conference services; patient education and screening services; marketing strategy and consulting services; digital marketing and sales solutions services; contract research organization services comprising patient recruitment and clinical data collection; internet hospital services via mobile applications such as Mediwelcome Doctor+ and Doctor+ for Doctor providing online follow-up consultations and e-prescriptions; digital therapy services; science research and development services; and IT and software services to pharmaceutical companies, medical associations, medical institutions, foundations, and patients. Founded in 2000 and headquartered at 17th Floor, Tower 7, Parkview Place, 2 East 4th Ring Road, Chaoyang District, Beijing, the company operates principally in China with platforms like Giraffe Smart Medical Platform, Medical Camp Platform, and Giraffe Doctor+ Internet Hospital Platform. In recent developments, the company advanced AIGC technology applications enhancing platform functionalities and launched a web 3.0-based digital asset management platform in June 2024 to assist doctors in managing and trading medical content copyrights; completed a share placement raising HK$21.3 million between June and July 2025 for general working capital to support business expansion; and reported interim revenue of RMB127.1 million for the six months ended 30 June 2025, with growth in marketing strategy and consulting services (RMB66.6 million) and digital marketing and sales solutions (RMB14.1 million), alongside registered doctor users reaching 781,606 on its digital medical platform and 56,154 on its internet medical platform.